Significance of the presence of microscopic vascular invasion after complete resection of stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-size categories: Did the 2009 7th edition of the TNM staging system miss something?

Journal of Thoracic Oncology

Volumn 6, Issue 2, 2011, Pages 319-326

  Ruffini, Enrico ^a   Asioli, Sofia ^a   Filosso, Pier Luigi ^a   Buffoni, Lucio ^b   Bruna, Maria Cristina ^a   Mossetti, Claudio ^a   Solidoro, Paolo ^b   Oliaro, Alberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Early stage; Lung cancer; Pathology; Surgery; Vessel invasion

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC VASCULAR INVASION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME;

EID: 79551526108     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182011f70     Document Type: Article

References (33)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Erratum in: CA Cancer J Clin 2005;55:259.
3. Goldstein NS, Mani A, Chmielewski G, et al. Prognostic factors in T1 NO MO adenocarcinomas and bronchioloalveolar carcinomas of the lung. Am J Clin Pathol 1999;112:391-402.
4. Tsuchiya T, Akamine S, Muraoka M, et al. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer 2007;56:341-348.
5. Kessler R, Gasser B, Massard G, et al. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg 1996;62:1489-1493.
6. Bodendorf MO, Haas V, Laberke HG, et al. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma. Lung Cancer 2009;64:71-78.
7. International Association for the Study of Lung Cancer. Staging Manual in Thoracic Oncology. Orange Park, FL: RX Press Ed., 2009.
8. Ruffini E, Asioli S, Filosso PL, et al. Clinical significance of tumorinfiltrating lymphocytes in lung neoplasms. Ann Thorac Surg 2009;87:365-371; discussion 371-372.
9. Anderson RP, Jin R, Grunkemeier GL. Understanding logistic regression analysis in clinical reports: an introduction. Ann Thorac Surg 2003;75:753-757.
10. Campbell MJ. Statistics at square two. BMJ: London, 2003.
11. Macchiarini P, Fontanini G, Hardin MJ, et al. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer. J Thorac Cardiovasc Surg 1993;106:80-89.
12. Shoji F, Haro A, Yoshida T, et al. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer. Ann Thorac Surg 2010;89:864-869.
13. Pignon JP, Tribodet H, Scagliotti GV, et al; LACE Collaborative Group. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552-3559.
14. Gabor S, Renner H, Popper H, et al. Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-smallcell lung cancer. Eur J Cardiothorac Surg 2004;25:439-442.
15. Mineo TC, Ambrogi V, Baldi A, et al. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol 2004;57:591-597.
16. Ichinose Y, Yano T, Asoh H, et al. Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage. J Thorac Cardiovasc Surg 1995;110:601-605.
17. Watanabe Y. Substaging of stage I: a commentary. Lung Cancer 2003;42:59-61.
18. Asioli S, Eusebi V, Gaetano L, et al. The pre-lymphatic pathway, the rooths of the lymphatic system in breast tissue: a 3D study. Virchows Arch 2008;453:401-406.
19. Rigau V, Molina TJ, Chaffaud C, et al. Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence. Lung Cancer 2002;38:169-176.
20. Fujisawa T, Yamaguchi Y, Saitoh Y, et al. Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected nonsmall cell carcinoma of the lung with intrapulmonary metastases. Cancer 1995;76:2464-2470.
21. Bréchot JM, Chevret S, Charpentier MC, et al. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival. Cancer 1996;78:2111-2118.
22. Suzuki K, Nagai K, Yoshida J, et al. Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg 2001;72:352-356.
23. Pechet TT, Carr SR, Collins JE, et al. Arterial invasion predicts early mortality in stage I non-small cell lung cancer. Ann Thorac Surg 2004;78:1748-1753.
24. Ogawa J, Tsurumi T, Yamada S, et al. Blood vessel invasion and expression of sialyl Lewisx and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence. Cancer 1994;73:1177-1183.
25. Harpole DH Jr, Herndon JE II, Young WG Jr, et al. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995;76:787-796.
26. Tsuchiya T, Hashizume S, Akamine S, et al. Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer. Chest 2007;132:170-177.
27. Poncelet AJ, Cornet J, Coulon C, et al; groupe d'oncologie thoracique des Cliniques Saint-Luc. Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma. Eur J Cardiothorac Surg 2008;33:799-804.
28. Hiraoka K, Miyamoto M, Cho Y, et al. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-smallcell lung carcinoma. Br J Cancer 2006;94:275-280.
29. Wakabayashi O, Yamazaki K, Oizumi S, et al. CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci 2003;94:1003-1009.
30. Ohtani H. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun 2007;7:4.
31. Nakano O, Sato M, Naito Y, et al. Proliferative activity of intratumoral CD8 (+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 2001;61:5132-5136.
32. Khan OA, Fitzgerald JJ, Field ML, et al. Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung. Ann Thorac Surg 2004;77:1173-1178.
33. Goldstraw P. Age does not influence early and late tumor-related outcome after surgery for bronchogenic carcinoma. Ann Thorac Surg 2000;69:678-679.